rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

NCT02340338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Toxic Shock Syndrome
Vaccination; Sepsis

Interventions

BIOLOGICAL: rTSST-1 Variant Candidate Vaccine

Sponsor

Biomedizinische Forschungs gmbH

Collaborators

[object Object]